When US President Donald Trump called Prime Minister of India Narendra Modi requesting the hydroxychloroquine stocks, it was clear that he is seeing this anti-malaria drug as a possible cure for the deadly Coronavirus.
In fact, such is Trump’s belief that he termed this drug as the game changer and when questioned by reporters on it this Monday, he said that if the drug isn’t allowed to come out then there may be retaliation.
India is the world’s largest producer of hydroxychloroquine on April 7th said that it has obligations of its own as the neighboring countries are also dependent on her during this crisis.
The official spokesperson of the Ministry of External Affairs said that India would licence paracetamol and HCQ in appropriate quantities to all our neighbouring countries who are dependent on our capabilities.
Hinting at Trump’s comments and the media storm that came after it he said that ‘India will also be supplying these essential drugs to some nations who have been particularly badly affected by the pandemic.’
Requesting to not politicize this matter he also said that:
After having confirmed the availability of medicines for all possible contingencies currently envisaged, these restrictions have been largely lifted. The DGFT has notified lifting restrictions on 14 drugs yesterday. With regard to paracetamol and Hydroxychloroquine (HCQ), they will be kept in a licensed category and their demand position would be continuously monitored. However, the stock position could allow our companies to meet the export commitments that they had contracted.
India and the US share cordial ties with each other, so it was just a matter of time for India to act anyways.
There are 4789 cases of coronavirus in India but due to the pressure of populations of SAARC nations and also its own, India has stopped supplying hydroxychloroquine.